Propensity matched comparison of TAVI and SAVR in intermediate-risk patients with severe aortic stenosis and moderate-to-severe chronic kidney disease: a subgroup analysis from the German Aortic Valve Registry.
Silvia Mas-PeiroGloria FaerberDimitra BonEva HerrmannTimm BauerSabine BleizifferRaffi BekeredjianAndreas BöningChristian FrerkerAndreas BeckmannHelge MöllmannStephan EnsmingerChristian W HammFriedhelm BeyersdorfStephan FichtlschererThomas Walthernull nullPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2022)
Both TAVI and SAVR led to comparable and excellent results in patients with moderate-to-severe CKD in an intermediate-risk population of patients with symptomatic severe aortic stenosis for whom both therapies could possibly be considered.
Keyphrases
- aortic stenosis
- aortic valve
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve replacement
- ejection fraction
- chronic kidney disease
- left ventricular
- early onset
- coronary artery disease
- end stage renal disease
- high intensity
- randomized controlled trial
- drug induced
- study protocol
- atrial fibrillation